Rydapt
List of products in the National Drug Code with proprietary name rydapt. Midostaurin is used to treat certain types of blood cell cancer (acute myeloid leukemia-AML, mast cell leukemia-MCL) or an immune system disorder (mastocytosis). It works by slowing or stopping the growth of cancer cells and certain immune system cells (mast cells).
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Product Type |
|---|---|---|---|---|---|---|
| 0078-0698 | Rydapt | Rydapt | Capsule, Liquid Filled | Oral | Novartis Pharmaceuticals Corporation | Human Prescription Drug |